Lofexidine
From Wikipedia, the free encyclopedia
Lofexidine
|
|
Systematic (IUPAC) name | |
2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole | |
Identifiers | |
CAS number | ? |
ATC code | N07BC04 |
PubChem | ? |
Chemical data | |
Formula | C11H12N2Cl2O |
Mol. weight | 259.131 g/mol |
Pharmacokinetic data | |
Bioavailability | >90% |
Protein binding | 80–90% |
Metabolism | Hepatic glucuronidation |
Half life | 11 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
POM(UK) |
Routes | Oral |
Lofexidine is an alpha2-adrenergic receptor agonist, can be used as a short acting (short half life) anti-hypertensive, but mostly used to help with relief from symptoms of heroin or opiate withdrawal in opiate dependency. Used primarily in the United Kingdom [1]. See also clonidine.
Antihypertensives (C02) and diuretics (C03) edit | ||
---|---|---|
Antiadrenergic agents (including alpha): |
Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine, Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine |
|
Vasodilators: |
Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine |
|
Other antihypertensives: | ||
Low ceiling diuretics: |
Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine |
|
High ceiling diuretics: | ||
Potassium-sparing diuretics: |